Jason S. Lewis
Jason S. Lewis
Verified email at
Cited by
Cited by
Imaging biomarker roadmap for cancer studies
JPB O'Connor, EO Aboagye, JE Adams, HJWL Aerts, SF Barrington, ...
Nature reviews Clinical oncology 14 (3), 169-186, 2017
A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy
KSC Chao, WR Bosch, S Mutic, JS Lewis, F Dehdashti, MA Mintun, ...
International Journal of Radiation Oncology* Biology* Physics 49 (4), 1171-1182, 2001
Copper radionuclides and radiopharmaceuticals in nuclear medicine
PJ Blower, JS Lewis, J Zweit
Nuclear medicine and biology 23 (8), 957-980, 1996
89Zr-DFO-J591 for immunoPET of prostate-specific membrane antigen expression in vivo
JP Holland, V Divilov, NH Bander, PM Smith-Jones, SM Larson, JS Lewis
Journal of Nuclear Medicine 51 (8), 1293-1300, 2010
In vivo assessment of tumor hypoxia in lung cancer with 60Cu-ATSM
F Dehdashti, MA Mintun, JS Lewis, J Bradley, R Govindan, R Laforest, ...
European journal of nuclear medicine and molecular imaging 30 (6), 844-850, 2003
Evaluation of 64Cu-ATSM in vitro and in vivo in a hypoxic tumor model
JS Lewis, DW McCarthy, TJ McCarthy, Y Fujibayashi, MJ Welch
Journal of Nuclear Medicine 40 (1), 177-183, 1999
Assessing tumor hypoxia in cervical cancer by positron emission tomography with 60Cu-ATSM: relationship to therapeutic response—a preliminary report
F Dehdashti, PW Grigsby, MA Mintun, JS Lewis, BA Siegel, MJ Welch
International Journal of Radiation Oncology* Biology* Physics 55 (5), 1233-1238, 2003
Standardized methods for the production of high specific-activity zirconium-89
JP Holland, Y Sheh, JS Lewis
Nuclear medicine and biology 36 (7), 729-739, 2009
Metal complexes as diagnostic tools
DE Reichert, JS Lewis, CJ Anderson
Coordination Chemistry Reviews 184 (1), 3-66, 1999
Imaging oxygenation of human tumours
AR Padhani, KA Krohn, JS Lewis, M Alber
European radiology 17 (4), 861-872, 2007
PET imaging with 89Zr: from radiochemistry to the clinic
MA Deri, BM Zeglis, LC Francesconi, JS Lewis
Nuclear medicine and biology 40 (1), 3-14, 2013
64Cu-TETA-octreotide as a PET imaging agent for patients with neuroendocrine tumors
CJ Anderson, F Dehdashti, PD Cutler, SW Schwarz, R Laforest, LA Bass, ...
Journal of Nuclear Medicine 42 (2), 213-221, 2001
Copper bis (thiosemicarbazone) complexes as hypoxia imaging agents: structure-activity relationships
JL Dearling, JS Lewis, GE Mullen, MJ Welch, PJ Blower
JBIC Journal of Biological Inorganic Chemistry 7 (3), 249-259, 2002
Cerenkov luminescence imaging of medical isotopes
A Ruggiero, JP Holland, JS Lewis, J Grimm
Journal of Nuclear Medicine 51 (7), 1123-1130, 2010
A pretargeted PET imaging strategy based on bioorthogonal Diels–Alder click chemistry
BM Zeglis, KK Sevak, T Reiner, P Mohindra, SD Carlin, P Zanzonico, ...
Journal of Nuclear Medicine 54 (8), 1389-1396, 2013
PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor–positive breast cancer
A Bosch, Z Li, A Bergamaschi, H Ellis, E Toska, A Prat, JJ Tao, DE Spratt, ...
Science translational medicine 7 (283), 283ra51-283ra51, 2015
Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90
K Moulick, JH Ahn, H Zong, A Rodina, L Cerchietti, EM Gomes DaGama, ...
Nature chemical biology 7 (11), 818-826, 2011
Small animal imaging: current technology and perspectives for oncological imaging
JS Lewis, S Achilefu, JR Garbow, R Laforest, MJ Welch
European journal of cancer 38 (16), 2173-2188, 2002
Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo
S Venneti, MP Dunphy, H Zhang, KL Pitter, P Zanzonico, C Campos, ...
Science translational medicine 7 (274), 274ra17-274ra17, 2015
Copper-64-diacetyl-bis(N4-methylthiosemicarbazone): An agent for radiotherapy
JS Lewis, R Laforest, TL Buettner, SK Song, Y Fujibayashi, JM Connett, ...
Proceedings of the National Academy of Sciences 98 (3), 1206-1211, 2001
The system can't perform the operation now. Try again later.
Articles 1–20